Salem Investment Counselors Inc Pfizer Inc Transaction History

Salem Investment Counselors Inc

  • $3.24 Billion
  • Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Pfizer Inc stock. As of the latest transaction made, Salem Investment Counselors Inc holds 130,501 shares of PFE stock, worth $3.58 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
130,501
Previous 131,882 1.05%
Holding current value
$3.58 Million
Previous $3.69 Million 2.33%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$27.7 - $31.39 $38,253 - $43,349
-1,381 Reduced 1.05%
130,501 $3.78 Million
Q2 2024

Jul 11, 2024
SELL
$25.26 - $29.6 $114,781 - $134,502
-4,544 Reduced 3.33%
131,882 $3.69 Million
Q1 2024

Apr 11, 2024
SELL
$25.89 - $29.73 $628,997 - $722,290
-24,295 Reduced 15.12%
136,426 $3.79 Million
Q4 2023

Jan 16, 2024
SELL
$26.13 - $33.94 $1.02 Million - $1.33 Million
-39,189 Reduced 19.6%
160,721 $4.63 Million
Q3 2023

Oct 04, 2023
SELL
$32.09 - $37.51 $7.74 Million - $9.05 Million
-241,261 Reduced 54.69%
199,910 $6.63 Million
Q2 2023

Jul 19, 2023
SELL
$36.12 - $41.79 $403,713 - $467,086
-11,177 Reduced 2.47%
441,171 $16.2 Million
Q1 2023

May 11, 2023
BUY
$39.39 - $51.28 $82,128 - $106,918
2,085 Added 0.46%
452,348 $18.5 Million
Q4 2022

Feb 15, 2023
SELL
$41.75 - $54.5 $386,605 - $504,670
-9,260 Reduced 2.02%
450,263 $23.1 Million
Q3 2022

Nov 09, 2022
BUY
$43.76 - $53.42 $1.37 Million - $1.67 Million
31,294 Added 7.31%
459,523 $20.1 Million
Q2 2022

Aug 17, 2022
SELL
$46.53 - $55.17 $36,339 - $43,087
-781 Reduced 0.18%
428,229 $22.5 Million
Q1 2022

May 16, 2022
BUY
$45.75 - $56.69 $711,183 - $881,246
15,545 Added 3.76%
429,010 $22.2 Million
Q4 2021

Feb 15, 2022
BUY
$41.32 - $61.25 $191,766 - $284,261
4,641 Added 1.14%
413,465 $24.4 Million
Q3 2021

Nov 15, 2021
BUY
$39.25 - $50.42 $544,476 - $699,426
13,872 Added 3.51%
408,824 $17.6 Million
Q2 2021

Aug 17, 2021
BUY
$35.91 - $40.68 $371,201 - $420,509
10,337 Added 2.69%
394,952 $15.5 Million
Q1 2021

May 17, 2021
BUY
$33.49 - $37.77 $1.23 Million - $1.39 Million
36,707 Added 10.55%
384,615 $13.9 Million
Q4 2020

Feb 17, 2021
BUY
$33.47 - $42.56 $1.11 Million - $1.41 Million
33,043 Added 10.49%
347,908 $12.8 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $1.09 Million - $1.28 Million
34,293 Added 12.22%
314,865 $11.6 Million
Q2 2020

Aug 13, 2020
BUY
$30.12 - $36.54 $1.05 Million - $1.28 Million
34,948 Added 14.23%
280,572 $9.18 Million
Q1 2020

May 14, 2020
SELL
$27.03 - $38.62 $405,233 - $578,991
-14,992 Reduced 5.75%
245,624 $8.02 Million
Q4 2019

Feb 13, 2020
BUY
$32.92 - $37.36 $50,828 - $57,683
1,544 Added 0.6%
260,616 $10.2 Million
Q3 2019

Nov 13, 2019
SELL
$32.49 - $42.13 $12,833 - $16,641
-395 Reduced 0.15%
259,072 $9.31 Million
Q2 2019

Aug 14, 2019
SELL
$36.98 - $41.52 $40,604 - $45,588
-1,098 Reduced 0.42%
259,467 $11.2 Million
Q1 2019

May 15, 2019
BUY
$37.5 - $41.2 $190,162 - $208,925
5,071 Added 1.98%
260,565 $11.5 Million
Q4 2018

Feb 15, 2019
SELL
$38.47 - $43.86 $195,081 - $222,414
-5,071 Reduced 1.95%
255,494 $11.2 Million
Q3 2018

Nov 14, 2018
SELL
$34.47 - $41.81 $674,371 - $817,970
-19,564 Reduced 6.98%
260,565 $11.5 Million
Q2 2018

Aug 15, 2018
SELL
$32.98 - $35.16 $272,183 - $290,175
-8,253 Reduced 2.86%
280,129 $10.2 Million
Q1 2018

May 15, 2018
SELL
$31.91 - $37.02 $300,751 - $348,913
-9,425 Reduced 3.16%
288,382 $10.3 Million
Q4 2017

Feb 16, 2018
BUY
$33.26 - $35.29 $70,843 - $75,167
2,130 Added 0.72%
297,807 $10.8 Million
Q3 2017

Nov 16, 2017
BUY
$31.0 - $34.15 $9.17 Million - $10.1 Million
295,677
295,677 $10.6 Million

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email